Diffusion Pharmaceuticals Financial Health
How is Diffusion Pharmaceuticals's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: DFFN's short term assets ($26.3M) exceed its short term liabilities ($2.3M).
Long Term Liabilities: DFFN has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: DFFN is debt free.
Reducing Debt: DFFN has no debt compared to 5 years ago when its debt to equity ratio was 8.7%.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DFFN has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: DFFN has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 6.2% each year.